ALYGLO
Live / Registered — Registered (as of 26 Nov 2024)
What this means for you
Registered since 26 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90160114
- Registration number
- 7580083
- Mark type
- Stylized text
- Filed
- 04 Sept 2020
- Published for opposition
- 20 Apr 2021
- Registered
- 26 Nov 2024
- Attorney of record
- KWANG YUP CHAE
Goods and services
- Class 005 — Pharmaceuticals: Blood plasma derivatives for medical purposes, namely, immune globulins including Rh immune globulin; Immunoglobulin reparations, namely, pharmaceutical immunoglobulin preparations for treatment of primary humoral immunodeficiency, Kawasaki disease, Guillain-Barre syndrome, common variable immune deficiency, X-linked agammaglobulinemia (XLA), hyper immunoglobulin M syndromes, Wiskott Aldrich Syndrome and severe combined immune deficiency (SCID), agammaglobulinemia, hypogammaglobulinemia, cardiovascular disease, inflammatory diseases, immunological disorders, bacterial infections, acute serious bacterial infection, chronic inflammatory demyelinating polyneuropathy (CIDP) and immune thrombocytopenic purpura (ITP); all the foregoing for patient treatment by injection or in liquid form by health professional
Owner
- GC BIOPHARMA CORP., Yongin-si, Gyeonggi-do, KR
- GC BIOPHARMA CORP., Yongin-si, Gyeonggi-do, KR
- Green Cross Corporation, Yongin-si, Gyeonggi-do, KR
- Green Cross Corporation, Yongin-si, Gyeonggi-do, KR
Prosecution history
- 26 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 24 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Oct 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Aug 2024 — USE AMENDMENT FILED
- 23 Oct 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Aug 2024 — TEAS STATEMENT OF USE RECEIVED
- 03 Apr 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 15 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2024 — SOU EXTENSION 4 GRANTED
- 14 Feb 2024 — SOU EXTENSION 4 FILED
- 14 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Aug 2023 — SOU EXTENSION 3 GRANTED